Optimising anti-PI3Kd and anti-LAG-3 immunotherapy dosing regimens in a mouse model of triple negative breast cancer improves outcome by removing treatment-related adverse events

Lauder, Sarah N., Pires, Ana, Somerville, Michelle, Capitani, Lorenzo, Smart, Kathryn, Geary, James, Mills, Emily M., Vanhaesebroeck, Bart, Godkin, Andrew

and Gallimore, Awen

2026. Optimising anti-PI3Kd and anti-LAG-3 immunotherapy dosing regimens in a mouse model of triple negative breast cancer improves outcome by removing treatment-related adverse events. Journal for ImmunoTherapy of Cancer
Item availability restricted.

	PDF - Accepted Post-Print Version Restricted to Repository staff only Download (21MB)
	PDF (Provisional file) - Accepted Post-Print Version Download (17kB)

Item Type:	Article
Status:	In Press
Schools:	Schools > Medicine Research Institutes & Centres > Systems Immunity Research Institute (SIURI)
Publisher:	BMJ Publishing Group
ISSN:	2051-1426
Date of First Compliant Deposit:	15 January 2026
Date of Acceptance:	10 January 2026
Last Modified:	15 Jan 2026 10:37
URI:	https://orca.cardiff.ac.uk/id/eprint/183915

Actions (repository staff only)

Edit Item

Download Statistics

Downloads

Downloads per month over past year

View more statistics

CORE (COnnecting REpositories)